| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | iZafe Group Achieves ISO/IEC 27001 Certification and Strengthens Its Position for International Expansion | 201 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / April 13, 2026 / iZafe Group (STO:IZAFE-B) - iZafe Group AB (publ) today announces that the company has obtained certification according to the international ISO/IEC... ► Artikel lesen | |
| Fr | iZafe Group: Monthly Update March - ADDA in Effect and Preparations for the Next Growth Phase | 312 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / April 10, 2026 / iZafe Group (STO:IZAFE-B) - March has been a month where several important milestones have been achieved for iZafe Group. The ADDA framework agreement... ► Artikel lesen | |
| 07.04. | iZafe Group: Dosell AB Awarded Contract with Region Jönköping County and its Municipalities | 253 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / April 7, 2026 / iZafe Group AB (publ)(STO:IZAFE-B) today announces that its subsidiary Dosell AB has been awarded a sub-contract within Region Jönköping County's procurement... ► Artikel lesen | |
| 01.04. | iZafe Group: Dosell AB Granted European Patent in Data-Driven Medication Management | 225 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / April 1, 2026 / iZafe Group (STO:IZAFE-B) - iZafe Group AB (publ) today announces that its subsidiary Dosell AB has been granted a European patent, EP4228584, titled... ► Artikel lesen | |
| 12.03. | iZafe Group: Dosell AB Signs Framework Agreement with Adda Following the End of the Appeal Period | 368 | ACCESS Newswire | STOCKHOLM, SWEDEN / ACCESS Newswire / March 12, 2026 / iZafe Group (STO:IZAFE-B) today announces that its subsidiary Dosell AB has signed a framework agreement with Adda Inköpscentral following the... ► Artikel lesen | |
| 12.03. | The observation status for iZafe Group AB is removed | 290 | GlobeNewswire | On February 17, 2026, the shares in iZafe Group AB (the "Company") were given observation status with reference to uncertainty in respect of the issuer's financial position.
On February 19, 2026... ► Artikel lesen | |
| IZAFE GROUP Aktie jetzt für 0€ handeln | |||||
| 12.03. | Communiqué from the Extraordinary General Meeting of iZafe Group AB | 308 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / March 12, 2026 / iZafe Group (STO:IZAFE-B) - An Extraordinary General Meeting was held in iZafe Group AB, reg. no. 556762-3391 (the "Company"), on 12 March 2026 at... ► Artikel lesen | |
| 12.03. | XFRA NEW INSTRUMENTS AVAILABLE ON 12.03.2026 | 734 | Xetra Newsboard | The following instruments on XETRA do have their first trading 12.03.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 12.03.2026
Aktien
1 SGXE65286994 Baidu Inc. SDR
2 SE0002402701... ► Artikel lesen | |
| 09.03. | iZafe Group: Monthly Letter February - ADDA, Growth Capital and Preparations for Scaling | 641 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / March 9, 2026 / iZafe Group (STO:IZAFE-B) - February has been a month where several important pieces have fallen into place for iZafe Group. We have been awarded a... ► Artikel lesen | |
| 26.02. | iZafe Group: Dosell Awarded Framework Agreement in Sweden's First National Procurement of Medication Dispensing Systems | 1.081 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / February 26, 2026 / iZafe Group (STO:IZAFE-B) - iZafe Group AB (publ) announces that its subsidiary Dosell AB has been awarded a framework agreement in ADDA's national... ► Artikel lesen | |
| 19.02. | iZafe Group AB has Resolved on a Directed Share Issue of Class B Shares of Approximately SEK 19.8 Million in Order to Accelerate the Pace of Sales and Installations | 345 | ACCESS Newswire | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, RUSSIA, BELARUS, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, OR IN... ► Artikel lesen | |
| 17.02. | iZafe Group AB receives observation status | 130 | GlobeNewswire | Yesterday, February 16, 2026, iZafe Group AB (the "Company") disclosed its annual financial statement release for 2025 with information on the Company's financial situation.
According to item... ► Artikel lesen | |
| 16.02. | iZafe Group's Quarterly Report Q4, October-December 2025 | 337 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / February 16, 2026 / iZafe Group AB (publ.)(STO:IZAFE-B) today, February 16, publishes its report for the fourth quarter.Financial Performance in SummaryThe Group's... ► Artikel lesen | |
| 10.02. | iZafe Group: Monthly Update January - Broad Momentum and the Launch of a New Platform | 351 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / February 10, 2026 / iZafe Group (STO:IZAFE-B) - 2026 has kicked off with continued high pace and several important developments in both the Swedish and international... ► Artikel lesen | |
| 21.01. | iZafe Group Launches Modular Display and Remote Care System - One Dosell for All Users | 398 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / January 21, 2026 / iZafe Group AB ("Company")(STO:IZAFE-B) today launches an external Display for Dosell together with a new remote care system featuring a web interface... ► Artikel lesen | |
| 12.01. | iZafe Group: Monthly Update December - A Year of Breakthroughs, Expansion and International Consolidation | 682 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / January 12, 2026 / iZafe Group (STO:IZAFE-B) - As we summarize December and at the same time leave 2025 behind, it is clear that the year has been one of the most transformative... ► Artikel lesen | |
| 16.12.25 | iZafe Group AB - Exercise of Warrants Under LTIP 2023 | 460 | ACCESS Newswire | STOCKHOLM, SWEDEN / ACCESS Newswire / December 16, 2025 / iZafe Group (STO:IZAFE-B) (the "Company") announces that all participants in the Company's long-term incentive program LTIP 2023 have exercised... ► Artikel lesen | |
| 08.12.25 | iZafe Group: Monthly Newsletter - November: Momentum, Deliveries, and Continued Expansion | 365 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / December 8, 2025 / iZafe Group (STO:IZAFE-B) - November marked yet another month of strong progress. New municipal rollouts, additional signed agreements, and continued... ► Artikel lesen | |
| 28.11.25 | Board Member Increases Shareholding in iZafe Group | 431 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / November 28, 2025 / iZafe Group (STO:IZAFE-B) - iZafe Group AB (publ.) announces that Board Member Anna Håkansson on 27 November 2025 increased her shareholding in... ► Artikel lesen | |
| 21.11.25 | iZafe Group Strengthens its Nordic Expansion through Strategic Partnership and First Major Deal in Norway | 379 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / November 21, 2025 / iZafe Group (STO:IZAFE-B) - announces that the company has entered into a strategic partnership with Vakt og Alarm, one of Norway's most established... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BRIGHTSPRING HEALTH SERVICES | 46,010 | 0,00 % | BrightSpring Health Services, Inc.: BrightSpring Health Services Completes Sale of ResCare Community Living to Sevita | LOUISVILLE, Ky., March 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based pharmacy and... ► Artikel lesen | |
| GERRESHEIMER | 21,020 | +18,76 % | Gerresheimer fliegt aus dem SDAX - Shelly Group rückt nach | Die Deutsche Börse nimmt zum 10. April 2026 eine außerplanmäßige Anpassung im SDAX vor. Die Aktie der Gerresheimer AG wird aus dem Index entfernt, weil das Unternehmen die Anforderung zur fristgerechten... ► Artikel lesen | |
| BILLIONTOONE | 80,61 | 0,00 % | BillionToOne, Inc.: BillionToOne to Report First Quarter 2026 Financial Results on May 6, 2026 | ||
| FRESENIUS MEDICAL CARE | 38,650 | -0,10 % | Shortseller-Positionen aktuell: u.a. Carl Zeiss Meditec, Evonik, FMC, Gerresheimer, GFT, MTU, Nordex, Ströer | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| FRESENIUS | 44,350 | +0,73 % | FRESENIUS SE & CO KGAA: Struktur in der Ruhe | ||
| SIEMENS HEALTHINEERS | 38,310 | -0,08 % | SIEMENS HEALTHINEERS AG im strategischen Gleichgewicht | ||
| BETA BIONICS | 13,020 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Announces Fourth Quarter and Full Year 2025 Financial Results and Introduces Annual Guidance for Full Year 2026 | IRVINE, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| HEARTFLOW | 29,190 | 0,00 % | Heartflow, Inc.: Heartflow Files Patent Infringement Lawsuit Against Cleerly | MOUNTAIN VIEW, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced that it has filed... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 25,700 | 0,00 % | PROCEPT BioRobotics to Report First Quarter 2026 Financial Results on April 29, 2026 | ||
| HIMS & HERS HEALTH | 21,860 | +6,12 % | Hims & Hers-Aktie: Neue Chancen nach dem Hype? | Die Aktie von Hims & Hers Health hat nach einer Zeit voller Hype und überschwänglichen Erwartungen in den vergangenen Monaten massiv gelitten. Nach einem deutlichen Kursrückgang rückt nun die Frage... ► Artikel lesen | |
| GENEDX | 67,32 | 0,00 % | Jefferies bestätigt Kaufempfehlung für GeneDx und verweist auf geringe Marktdurchdringung | ||
| PROGYNY | 17,400 | 0,00 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 20,920 | 0,00 % | Alignment Healthcare Reports Fourth Quarter and Full-Year 2025 Results; Beats High-End of Guidance Across All Key Metrics | Delivers full-year revenue of $3.95 billion, representing 46.1% growth year-over-year Exceeds high-end of fourth quarter and full-year guidance across all key metrics: membership, revenue, adjusted... ► Artikel lesen | |
| ANTERIS TECHNOLOGIES GLOBAL | 6,290 | 0,00 % | ANTERIS TECHNOLOGIES GLOBAL CORP.: Notification regarding unquoted securities - AVR | ||
| RXSIGHT | 7,215 | 0,00 % | RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer | ALISO VIEJO, Calif., Jan. 11, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following... ► Artikel lesen |